On the Horizon – Denosumab, An alternative To Zometa To Protect Bones While Treating Advanced Prostate Cancer
Second of Three Pivotal Phase Three Bone Metastases Trials Meets Primary Endpoint Denosumab Delayed Time to Skeletal Related Events Amgen (NASDAQ: AMGN) has announced positive results from a Phase III head-to-head trial evaluating denosumab administered [...]
How a Prostate Cancer Recurrence Is Currently Dealt With – Salvage Methods For Recurrent Prostate Cancer After Failure Of PrimaryRadiotherapy
The authors of a recent study from the Duke Prostate Center and Division of Urology, Department of Surgery, Duke University Medical Center, Durham, N.C. and the Department of Urology, Kitasato University School of Medicine, Kanagawa, [...]
Combined Androgen Blockade (ADT2) with Bicalutamide (Casodex) For Advanced Prostate Cancer Provides Increased Survival Time
One of the first treatments used when diagnosed with advanced or recurrent prostate cancer is hormone therapy. Hormone therapy (androgen blockade) is a systematic treatment, or it treats the cancer through the entire body. Prostate [...]
On the Horizon – Positive Efficacy Data From Phase I – II Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
Medivation, Inc. (MDVN) announced that its on-going clinical trial (phase I & II) of MDV3100 in castrate resistant prostate cancer has demonstrated both efficacy and safety in its current trials. The drug under study, MDV3100, [...]
Cancer Survivors Face Psychological Difficulties, Even After Treatment Ends
We all do know that being a cancer survivor means that you are at an increased risk to suffer serious psychological distress such as anxiety and depression The surprise is that this increased susceptibility can [...]
Senator Dodd and the future of PSA Testing
As we all have probably have heard Senator Christopher J. Dodd of Connecticut announced that he had prostate cancer. According to his announcement he had a biopsy as a result of a blood test. We [...]